Vivani Medical VANI Proceeds From Issuance Of Common Stock In Connection With Private Sales Transaction Net Of Issuance Costs
Proceeds From Issuance Of Common Stock In Connection With Private Sales Transaction Net Of Issuance Costs at other companies
Other financials
Where this comes from
Reported directly by Vivani Medical in its filing.
Tagged under the XBRL concept vani:ProceedsFromIssuanceOfCommonStockInConnectionWithPrivateSalesTransactionNetOfIssuanceCosts.
The official record: Vivani Medical’s 10-K, filed March 26, 2026, on SEC EDGAR. View the filing →
Ask your AI about Vivani Medical's proceeds from issuance of common stock in connection with private sales transaction net of issuance costs.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Vivani Medical's proceeds from issuance of common stock in connection with private sales transaction net of issuance costs?
- Vivani Medical (VANI) reported proceeds from issuance of common stock in connection with private sales transaction net of issuance costs of $2.14M in Q4 2025.
- What does proceeds from issuance of common stock in connection with private sales transaction net of issuance costs mean?
- This metric measures the net cash inflow from private sales of common stock to institutional or accredited investors. It serves as a key indicator of the company's ability to secure private funding outside of public market offerings to support development pipelines.